4//SEC Filing
Polaris Management Co. VII, L.L.C. 4
Accession 0000899243-20-030317
CIK 0001604477other
Filed
Nov 2, 7:00 PM ET
Accepted
Nov 3, 8:00 PM ET
Size
34.8 KB
Accession
0000899243-20-030317
Insider Transaction Report
Form 4
Polaris Partners VII, L.P.
10% Owner
Transactions
- Conversion
Common Stock
2020-11-03+2,315,652→ 2,315,652 total(indirect: See footnotes) - Conversion
Series C Convertible Preferred Stock
2020-11-03−630,672→ 0 total(indirect: See footnotes)→ Common Stock (664,097 underlying) - Purchase
Common Stock
2020-11-03$16.00/sh+233,654$3,738,464→ 2,549,306 total(indirect: See footnotes) - Conversion
Series C Convertible Preferred Stock
2020-11-03−44,120→ 0 total(indirect: See footnotes)→ Common Stock (46,458 underlying) - Conversion
Series A Convertible Preferred Stock
2020-11-03−412,608→ 0 total(indirect: See footnotes)→ Common Stock (434,476 underlying) - Conversion
Series D Convertible Preferred Stock
2020-11-03−24,397→ 0 total(indirect: See footnotes)→ Common Stock (25,690 underlying) - Conversion
Common Stock
2020-11-03+161,994→ 161,994 total(indirect: See footnotes) - Purchase
Common Stock
2020-11-03$16.00/sh+16,346$261,536→ 178,340 total(indirect: See footnotes) - Conversion
Series A Convertible Preferred Stock
2020-11-03−28,863→ 0 total(indirect: See footnotes)→ Common Stock (30,392 underlying) - Conversion
Series B Convertible Preferred Stock
2020-11-03−807,096→ 0 total(indirect: See footnotes)→ Common Stock (849,872 underlying) - Conversion
Series B Convertible Preferred Stock
2020-11-03−56,462→ 0 total(indirect: See footnotes)→ Common Stock (59,454 underlying) - Conversion
Series D Convertible Preferred Stock
2020-11-03−348,725→ 0 total(indirect: See footnotes)→ Common Stock (367,207 underlying)
Polaris Management Co. VII, L.L.C.
10% Owner
Transactions
- Conversion
Common Stock
2020-11-03+2,315,652→ 2,315,652 total(indirect: See footnotes) - Purchase
Common Stock
2020-11-03$16.00/sh+16,346$261,536→ 178,340 total(indirect: See footnotes) - Conversion
Series B Convertible Preferred Stock
2020-11-03−807,096→ 0 total(indirect: See footnotes)→ Common Stock (849,872 underlying) - Conversion
Series C Convertible Preferred Stock
2020-11-03−44,120→ 0 total(indirect: See footnotes)→ Common Stock (46,458 underlying) - Conversion
Series C Convertible Preferred Stock
2020-11-03−630,672→ 0 total(indirect: See footnotes)→ Common Stock (664,097 underlying) - Conversion
Common Stock
2020-11-03+161,994→ 161,994 total(indirect: See footnotes) - Purchase
Common Stock
2020-11-03$16.00/sh+233,654$3,738,464→ 2,549,306 total(indirect: See footnotes) - Conversion
Series A Convertible Preferred Stock
2020-11-03−28,863→ 0 total(indirect: See footnotes)→ Common Stock (30,392 underlying) - Conversion
Series A Convertible Preferred Stock
2020-11-03−412,608→ 0 total(indirect: See footnotes)→ Common Stock (434,476 underlying) - Conversion
Series B Convertible Preferred Stock
2020-11-03−56,462→ 0 total(indirect: See footnotes)→ Common Stock (59,454 underlying) - Conversion
Series D Convertible Preferred Stock
2020-11-03−24,397→ 0 total(indirect: See footnotes)→ Common Stock (25,690 underlying) - Conversion
Series D Convertible Preferred Stock
2020-11-03−348,725→ 0 total(indirect: See footnotes)→ Common Stock (367,207 underlying)
Transactions
- Conversion
Series B Convertible Preferred Stock
2020-11-03−807,096→ 0 total(indirect: See footnotes)→ Common Stock (849,872 underlying) - Conversion
Series C Convertible Preferred Stock
2020-11-03−44,120→ 0 total(indirect: See footnotes)→ Common Stock (46,458 underlying) - Conversion
Series C Convertible Preferred Stock
2020-11-03−630,672→ 0 total(indirect: See footnotes)→ Common Stock (664,097 underlying) - Conversion
Series D Convertible Preferred Stock
2020-11-03−348,725→ 0 total(indirect: See footnotes)→ Common Stock (367,207 underlying) - Conversion
Series D Convertible Preferred Stock
2020-11-03−24,397→ 0 total(indirect: See footnotes)→ Common Stock (25,690 underlying) - Purchase
Common Stock
2020-11-03$16.00/sh+16,346$261,536→ 178,340 total(indirect: See footnotes) - Purchase
Common Stock
2020-11-03$16.00/sh+233,654$3,738,464→ 2,549,306 total(indirect: See footnotes) - Conversion
Series B Convertible Preferred Stock
2020-11-03−56,462→ 0 total(indirect: See footnotes)→ Common Stock (59,454 underlying) - Conversion
Common Stock
2020-11-03+161,994→ 161,994 total(indirect: See footnotes) - Conversion
Common Stock
2020-11-03+2,315,652→ 2,315,652 total(indirect: See footnotes) - Conversion
Series A Convertible Preferred Stock
2020-11-03−28,863→ 0 total(indirect: See footnotes)→ Common Stock (30,392 underlying) - Conversion
Series A Convertible Preferred Stock
2020-11-03−412,608→ 0 total(indirect: See footnotes)→ Common Stock (434,476 underlying)
Footnotes (4)
- [F1]Each share of preferred stock automatically converted on a 1.053 for one basis into common stock upon the closing of the Issuer's initial public offering. The shares have no expiration date.
- [F2]These shares are held of record by Polaris Entrepreneurs' Fund VII, L.P. ("EF VII"). Polaris Management Co. VII, L.L.C. ("PMC VII") is the general partner of EF VII. David Barrett, Brian Chee, Amir Nashat and Bryce Youngren (the "Managing Members") are the managing members of PMC VII. Amy Schulman ("Ms. Schulman"), a member of the Issuer's board of directors, holds an interest in PMC VII.
- [F3]Each of the Managing Members and Ms. Schulman, in their respective capacities with respect to PMC VII, may be deemed to have shared investment, voting and dispositive power over these shares. Each of PMC VII, the Managing Members and Ms. Schulman disclaim beneficial ownership of these shares and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein.
- [F4]These shares are held of record by Polaris Partners VII, L.P ("PP VII"). PMC VII is the general partner of PP VII. The Managing Members are the managing members of PMC VII. Ms. Schulman, a member of the Issuer's board of directors, holds an interest in PMC VII.
Documents
Issuer
SQZ Biotechnologies Co
CIK 0001604477
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001678203
Filing Metadata
- Form type
- 4
- Filed
- Nov 2, 7:00 PM ET
- Accepted
- Nov 3, 8:00 PM ET
- Size
- 34.8 KB